Literature DB >> 17329568

American Society of Nephrology Presidential Address 2006: chronic kidney disease as a public health threat--new strategy for a growing problem.

Thomas D DuBose1.   

Abstract

Entities:  

Mesh:

Year:  2007        PMID: 17329568     DOI: 10.1681/ASN.2006121347

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  7 in total

1.  The pattern, clinical characteristics and outcome of ESRD in Ile-Ife, Nigeria: is there a change in trend?

Authors:  F A Arogundade; A A Sanusi; M O Hassan; A Akinsola
Journal:  Afr Health Sci       Date:  2011-12       Impact factor: 0.927

2.  Defining incident chronic kidney disease in the research setting: The ARIC Study.

Authors:  Lori D Bash; Josef Coresh; Anna Köttgen; Rulan S Parekh; Tibor Fulop; Yaping Wang; Brad C Astor
Journal:  Am J Epidemiol       Date:  2009-06-17       Impact factor: 4.897

3.  Poor glycemic control in diabetes and the risk of incident chronic kidney disease even in the absence of albuminuria and retinopathy: Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Lori D Bash; Elizabeth Selvin; Michael Steffes; Josef Coresh; Brad C Astor
Journal:  Arch Intern Med       Date:  2008-12-08

Review 4.  Neurological complications of chronic kidney disease.

Authors:  Arun V Krishnan; Matthew C Kiernan
Journal:  Nat Rev Neurol       Date:  2009-09-01       Impact factor: 42.937

Review 5.  Overview of the cellular and molecular basis of kidney fibrosis.

Authors:  Allison A Eddy
Journal:  Kidney Int Suppl (2011)       Date:  2014-11

Review 6.  On the rationale of population screening for chronic kidney disease: a public health perspective.

Authors:  Murielle Bochud
Journal:  Public Health Rev       Date:  2015-11-05

7.  pH-mediated upregulation of AQP1 gene expression through the Spi-B transcription factor.

Authors:  Yihui Zhai; Hong Xu; Qian Shen; Franz Schaefer; Claus P Schmitt; Jing Chen; Haimei Liu; Jialu Liu; Jiaojiao Liu
Journal:  BMC Mol Biol       Date:  2018-03-20       Impact factor: 2.946

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.